Institutional Ownership
Anavex Life Sciences Corp
CUSIP 032797300COM NEWAVXLQ1 2026
13D / 13G Filings
14
Schedule 13D/13G on record
Beneficial Filers
4
Distinct reporting persons
Largest Stake
8.1%
Max % of class reported
Institutional Holders
183
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
14 filings · latest Feb 13, 2024
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 5.3% | 4.36M | SEC |
| 2 | Jan 25, 2024 | Blackrock Inc. | 13G/A | 8.1% | 6.67M | SEC |
| 3 | Jan 22, 2024 | State Street Corp | 13G/A | 4.4% | — | SEC |
| 4 | Feb 9, 2023 | Vanguard Group Inc | 13G/A | 5.3% | 4.14M | SEC |
| 5 | Feb 9, 2023 | State Street Corp | 13G/A | 7.5% | — | SEC |
| 6 | Jan 31, 2023 | Blackrock Inc. | 13G/A | 7.2% | 5.58M | SEC |
| 7 | Feb 9, 2022 | Vanguard Group Inc | 13G | 5.0% | 3.84M | SEC |
| 8 | Feb 9, 2022 | State Street Corp | 13G | 5.0% | — | SEC |
| 9 | Feb 3, 2022 | Blackrock Inc. | 13G/A | 6.9% | 5.26M | SEC |
| 10 | Feb 16, 2021 | Park West Asset Management LLC | 13G/A | — | — | SEC |
4 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Anavex Life Sciences Corp.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 7.61M | $23.36M |
| 2 | State Street Corp | 4.51M | $13.85M |
| 3 | Two Sigma Investments, LP | 3.25M | $9.97M |
| 4 | Geode Capital Management, LLC | 2.19M | $6.72M |
| 5 | Susquehanna International Group, LLP | 995.7K | $3.06M |
| 6 | Summit Financial, LLC | 940.5K | $2.89M |
| 7 | Bank Of America Corp /De/ | 863.1K | $2.65M |
| 8 | Goldman Sachs Group Inc | 804.4K | $2.47M |
| 9 | Aqr Capital Management LLC | 756.8K | $2.32M |
| 10 | Charles Schwab Investment Management Inc | 756.6K | $2.32M |